Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders: new opportunities for synergy with psychotherapy.
Krystal
John H
JH
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. john.krystal@yale.edu
D003131:Combined Modality Therapy; D003523:Cycloserine / Q000627:therapeutic use*; D015195:Drug Design; D018683:Excitatory Amino Acid Agents / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D009473:Neuronal Plasticity / Q000187:drug effects* / Q000502:physiology; D011613:Psychotherapy / Q000379:methods; D013237:Stereoisomerism
D018683:Excitatory Amino Acid Agents; D003523:Cycloserine